Real World Benefits of Mepolizumab in Patients With Severe Asthma and Comorbid Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Post Hoc Analysis of REALITI-A - 03/02/23
Doi : 10.1016/j.jaci.2022.12.054
Frances Lee, MD 1, Mark Liu, MD FAAAAI 2, Diego Bagnasco 3, Andrea Matucci, MD 4, Charles Pilette 5, Robert Price 6, Rafael Alfonso-Cristancho 7, Rupert Jakes 8, Peter Howarth, MD, BSc DM FRCP FF 9
1 Emory University, GA, USA
2 Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA
3 University of Genoa, Ospedale Policlinico San Martino, Genoa, Italy
4 University of Florence, Florence, Italy
5 Cliniques Universitaires Saint-Luc, Brussels, Belgium
6 GSK, Stevenage, Hertfordshire, UK
7 GSK, Collegeville, PA, USA
8 GSK, London, UK
9 GSK, Brentford, Middlesex, UK
048
Il testo completo di questo articolo è disponibile in PDF.Mappa
© 2022
Pubblicato da Elsevier Masson SAS.
Vol 151 - N° 2S
P. AB15 - Febbraio 2023 Ritorno al numero
Articolo precedente
- Long-Term Dupilumab Treatment Effect On Safety And Clinical Efficacy In Children With Type 2 Asthma: LIBERTY ASTHMA EXCURSION
- Leonard Bacharier, Jorge Maspero, Constance Katelaris, Alessandro Fiocchi, Remi Gagnon, Ines de Mir, Theresa Guilbert, Daniel Jackson, Ning Li, Bolanle Akinlade, Elizabeth Laws, Leda Mannent, Jennifer Maloney, Kelsey Tawo, Faisal Khokhar, Megan Hardin, Raolat Abdulai, David Lederer, Lacey Robinson
- Albuterol-budesonide Fixed-dose Combination (FDC) Inhaler As-needed Reduces Progression from Symptomatic Deterioration to Severe Exacerbation in Patients with Moderate-to-severe Asthma: Analysis from MANDALA
- Bradley Chipps, Alberto Papi, Frank Albers, Mark Cooper, Ileen Gilbert, Carin Jorup, Frank Trudo, Christy Cappelletti, Mark Weinberg
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?